Allan Reine
Director of Finance/CFO at PRIME MEDICINE, INC.
Net worth: 360 891 $ as of 30/03/2024
Profile
Allan Jacob Reine is an Independent Non-Executive Director at ONK Therapeutics Ltd.
and the Chief Financial Officer at Prime Medicine, Inc. He previously worked as an Analyst at CIBC World Markets Corp., a Portfolio Manager at S.A.C.
Capital Advisors LP, a Research Analyst at Alexandra Investment Management LLC, a Portfolio Manager at Citigroup Alternative Investments LLC, a Principal at Trivium Capital Management LLC, a Portfolio Manager at CR Intrinsic Investors LLC, and a Healthcare Portfolio Manager at Citi Principal Strategies.
He also served as the Chief Financial & Accounting Officer, Treasurer at Pieris Pharmaceuticals, Inc. and the Chief Financial Officer at Foghorn Therapeutics, Inc. Dr. Reine holds a doctorate degree from the University of Toronto and an undergraduate degree from the University of Western Ontario.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
15/01/2024 | 53,784 ( 0.13% ) | 360 891 $ | 30/03/2024 |
Allan Reine active positions
Companies | Position | Start |
---|---|---|
PRIME MEDICINE, INC. | Director of Finance/CFO | 16/01/2024 |
ONK Therapeutics Ltd.
ONK Therapeutics Ltd. BiotechnologyHealth Technology ONK Therapeutics Ltd. develops bio cells for anti cancer therapies. The company was founded by Michael O'Dwyer and Anthony Killarney in 2015 and is headquartered in Galway, Ireland. | Director/Board Member | 22/03/2022 |
Former positions of Allan Reine
Companies | Position | End |
---|---|---|
FOGHORN THERAPEUTICS INC. | Director of Finance/CFO | 15/01/2024 |
PIERIS PHARMACEUTICALS, INC. | Director of Finance/CFO | 12/09/2019 |
Citigroup Alternative Investments LLC
Citigroup Alternative Investments LLC Investment ManagersFinance Citigroup Alternative Investments LLC (CAI) is a registered investment advisor headquartered in New York City. The firm was founded in 2002 and is a wholly-owned subsidiary of Citigroup Investments, Inc., which is owned by Citigroup, Inc. (NYSE: C). CAI provides advisory services to private investment companies such as private equity funds and funds of one or more private equity and real estate funds. The investors of the funds advised by the firm are institutional investors, funds of funds, high net worth individuals and employees and former employees of Citigroup, Inc. | Portfolio Manager-Equities | 31/01/2012 |
S.A.C. Capital Advisors LP
S.A.C. Capital Advisors LP Investment ManagersFinance Founded by Steven A. Cohen in 1992, S.A.C. Capital Advisors LP is a hedge fund manager located in Stamford, Connecticut with offices in New York City, Chicago and Boston. | Analyst-Equity | 30/12/2007 |
Trivium Capital Management LLC
Trivium Capital Management LLC Investment ManagersFinance Founded in 2002, Trivium Capital Management LLC is a New York City-based hedge fund manager. They manage the Trivium Offshore Fund Ltd. | Head-Equity Investments | 31/07/2008 |
Training of Allan Reine
University of Toronto | Doctorate Degree |
University of Western Ontario | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
PIERIS PHARMACEUTICALS, INC. | Health Technology |
FOGHORN THERAPEUTICS INC. | Health Technology |
PRIME MEDICINE, INC. | Health Technology |
Private companies | 9 |
---|---|
CIBC World Markets Corp. (Old)
CIBC World Markets Corp. (Old) Financial ConglomeratesFinance CIBC World Markets is a full-service investment bank headquartered in New York City. CIBC provides an internationally integrated research product through three primary strategies. In the US, the firm provides research coverage available in areas of focus, including technology, telecommunications, healthcare, energy, power generation and technology, financial institutions, consumer growth, real estate and media. In Canada, the firm offers the full spectrum of coverage for all of the sectors that form the TSE 300 Index. Their broad investment grade analysis of return bond Indices provides daily performance of the Canadian bond market. The sectors covered are: government of Canada bonds, provincial and municipal bonds and corporate bonds rated AAA/AA, A and BBB. Also available is a monthly ABS/MBS market report that provides information on ABS market conditions, market summary data and monthly performance reports on outstanding transactions. This report includes information about the MBS market, including key statistics on MBS spreads and prepayments. Another report contains MBS trading data, cash flows and other key data. A separate monthly Portfolio Valuation Report provides month end pricing for ABS and MBS transactions. Corporate debt research produces highly targeted credit analysis and research for investment grade and high yield debt securities. The corporate bond review covers bond market action, new issues, price/yield movements, rating changes, and buy/sell recommendations. The fixed-income research group produces actionable fundamental and technical analysis, strategies, products, and runs bond indexes and quantitative models relating specifically to fixed income markets, bond portfolios, and individual securities. CIBC provides risk management solutions to corporations, investors, financial institutions, and governments across all asset classes: interest rates, equities, credit, currency, and commodities. CIBC World Markets is a subsidiary of Canadian Imperial Bank of Commerce. | Finance |
S.A.C. Capital Advisors LP
S.A.C. Capital Advisors LP Investment ManagersFinance Founded by Steven A. Cohen in 1992, S.A.C. Capital Advisors LP is a hedge fund manager located in Stamford, Connecticut with offices in New York City, Chicago and Boston. | Finance |
Alexandra Investment Management LLC
Alexandra Investment Management LLC Investment ManagersFinance Founded in 1993, Alexandra Investment Management LLC is a New York City-based alternative investment firm | Finance |
Citigroup Alternative Investments LLC
Citigroup Alternative Investments LLC Investment ManagersFinance Citigroup Alternative Investments LLC (CAI) is a registered investment advisor headquartered in New York City. The firm was founded in 2002 and is a wholly-owned subsidiary of Citigroup Investments, Inc., which is owned by Citigroup, Inc. (NYSE: C). CAI provides advisory services to private investment companies such as private equity funds and funds of one or more private equity and real estate funds. The investors of the funds advised by the firm are institutional investors, funds of funds, high net worth individuals and employees and former employees of Citigroup, Inc. | Finance |
Trivium Capital Management LLC
Trivium Capital Management LLC Investment ManagersFinance Founded in 2002, Trivium Capital Management LLC is a New York City-based hedge fund manager. They manage the Trivium Offshore Fund Ltd. | Finance |
Lombard Odier Asset Management (USA) Corp.
Lombard Odier Asset Management (USA) Corp. Investment ManagersFinance Lombard Odier Asset Management (USA) Corp. (LOAM) is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2000 and do-business-as Lombard Odier Investment Managers. The firm is a subsidiary of LO Holding SA and their ultimate parent is Switzerland-based Compagnie Lombard Odier SCmA. LOAM provides investment advisory services on a discretionary basis to private pooled investment vehicles (Funds) and investment advisory accounts. The investors in the Funds consist of endowments, foundations, insurance companies, high net-worth individuals, funds of funds, public and corporate pensions, and other sophisticated investors. | Finance |
CR Intrinsic Investors LLC
CR Intrinsic Investors LLC Investment ManagersFinance Founded in 2005, CR Intrinsic Investors LLC is a hedge fund manger located in Stamford, Connecticut with an additional office in New York City. CR Intrinsic is a subsidiary of SAC Capital Advisors LP. | Finance |
ONK Therapeutics Ltd.
ONK Therapeutics Ltd. BiotechnologyHealth Technology ONK Therapeutics Ltd. develops bio cells for anti cancer therapies. The company was founded by Michael O'Dwyer and Anthony Killarney in 2015 and is headquartered in Galway, Ireland. | Health Technology |
Citi Principal Strategies | Finance |
- Stock Market
- Insiders
- Allan Reine